ABSTRACr A study has been made of 8781 patients with bronchial carcinoma who were operated on by seven surgeons in England during the years 1949-80. There were 3865 pneumonectomies, 3790 lobectomies, and 1126 thoracotomies. During this period the operative mortality has fallen. Neither the resection rate nor the proportion of lobectomies bears any relation to the survival rate in any series. There has been remarkable similarity between the various survival rates in that the difference at five years was only 1*3% (25.5-26.8%) and at 10 years 4-2% (13.6-17-8%). These figures are reflected in reports published worldwide, where there is also great similarity between the results. If the improvement in operative mortality is excluded, there has been no improvement in the survival rates in the last thirty years.
The incidence of bronchial carcinoma has risen steadily in many countries during the last 30 years. In the United Kingdom it has been the commonest neoplasm among men for a long time; among women it is now second only to carcinoma of the breast and the gap is narrowing. We therefore thought it would be worthwhile to study the results of surgery for this disease performed by a group of surgeons in England during this period, to see whether the results had improved and to look at some other factors which might be of interest to future generations.
Material and operative trends
Reports were received from seven surgeons on 8781 patients who had been operated on for bronchial carcinoma from 1949 to 1980 (table 1). All the surgeons worked in or around London, except for one (RAS) who was based in Coventry. Each was asked to give the total number of patients in his series, the operative mortality, the resection rate, the proportion of lobectomies, and the survival rates at five and 10 years and subsequently. Two (fig 2) . Similarly, if ed with the lobectomy were an inadequate operation in the treatment of bronchial carcinoma, the series with "lobectomy the largest proportion of these might be expected to *onchial car-have had the lowest survival rate. This again was not nss at a time shown to be so (fig 3) . Thus the twin policies of be the treat-"resection at all costs" and "lobectomy where posswas adopted ible" seem to have been vindicated. 
Resection rates varied more widely, ranging in this series from 78% to 97 5%. The variation in previously published reports is greater, with one rate as low as 52%;12 but this has no influence on the survival rate, as shown in this and other publications (table 5) . This in turn confirms the importance of the policy first recommended by Abbey Smith of "resection at all costs."48
This report also shows that the proportion of lobectomies had no influence on the survival rate. This too is confirmed in previous reports, the rate varying from 28%'3 to 78% (MMB and RR) (fig 4) . Thus the policy of "lobectomy where possible" has also been proved to be right.
The great similarity between survival rates at five years was first commented on in 1965 '4 and is amply confirmed in the series reported here, where the maximum difference in five large series was only 1-3%. This similarity is mirrored in reports published worldwide: among reported series of more than 1000 operations the variation is only 5-3% and if the Mayo Clinic series 6 is excluded it is only 2% (table 5).
As there are well-known variables, such as tumour size and the extent of glandular disease, which influence survival rates, the remarkable similarity of reported results implies that the proportion of patients with the different variants in any given series is likely also to have been similar. The staging Mountain'7 has said that a 55% chance of survival at five years can be held out to patients with small squamous-cell tumours; but this cannot be a basis for selection of patients for surgery, and despite great efforts in many centres with preoperative investigation and adjuvant treatment22 the position seems to be much the same as it was in 1950.
For 10-year survival the difference between the highest and the lowest rates reported here was 4.2%; the rates reported by other authors are largely within the same range (table 6). Many of these series were small, but again it is surprising how alike they are.
Lastly, the close similarity in the proportion of patients who died late after resection from bronchial carcinoma reported by the two surgeons who had this information8 20 is remarkable, being almost identical after five and 10 years. Perhaps even more surprisingly, Watson23 reported a difference of only 4% between five and 10 years and exactly the same after 10 years, although the numbers were small. Ashor et al '9 also refers to the high risk of late death from bronchial carcinoma after resection; on the other hand, Shields and Robinette22 report a very different experience, with only 13% of their deaths after five years due to bronchial carcinoma. All have emphasised the importance of long-term follow-up in the light of these findings.
Thus not only the figures quoted here but also those published elsewhere show great similarity despite variations of geography, social customs, the age of the patients, the indications for operation, the resection rate, and the lobectomy rate. Nor have they changed significantly during the period under review, and the disease process itself must be the dominant factor influencing the results.
